The findings underscore the profound impact of obesity and glycemic status on insulin resistance and lipid abnormalities while also suggesting that APOA1 genotype may not independently influence these metabolic outcomes within obese subgroups. The gene discussed is APOA1; the disease is Insulin resistance.